SCHEMBL7715747

SCHEMBL7715747

NC(CCS(N)(=O)=O)C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.51
CA2 P00918 5/20 0.51
CA9 Q16790 3/20 0.51
CA12 O43570 2/20 0.51
IDO1 P14902 1/20 0.46
ALDH1A1 P00352 3/20 0.46
SLC1A3 P43003 3/20 0.45
SLC1A1 P43005 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
SLC15A1 P46059 1/20 0.44
LTA4H P09960 1/20 0.44
LAP3 P28838 1/20 0.44
SLC1A2 P43004 2/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27887665 0.86 CA1 (0.53) CA1CA2CA9CA12IDO1
SCHEMBL4161005 0.83 IDO1 (0.53) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL10441465 0.83 IDO1 (0.53) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL1245400 0.82 ALDH1A1 (0.50) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL3471267 0.82 SLC1A1 (0.55) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL5019164 0.82 ALDH1A1 (0.50) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL535584 0.82 ALDH1A1 (0.50) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL22433276 0.82 ALDH1A1 (0.50) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL22433275 0.82 ALDH1A1 (0.50) IDO1ALDH1A1SLC1A3SLC1A1TDP1
SCHEMBL5618771 0.82 SLC1A1 (0.55) IDO1ALDH1A1SLC1A3SLC1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436691-B1 CONJUGATE WHICH IS SUBSTANTIALLY NON-IMMUNOGENIC IN HUMANS COMPRISING TARGETING MOIETY CAPABLE OF BINDING WITH TUMOR ASSOCIATED ANTIGEN LINKED TO MUTATED FORM OF CARBOXYPEPTIDASE B ENZYME CAPABLE OF CONVERTING PRODRUG INTO ANTICANCER DRUG ZENECA LIMITED (GB) 2002-08-20 US disclosed
EP-0844885-A2 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1998-06-03 EP disclosed
WO-1997007769-A2 CHEMICAL COMPOUNDS ZENECA LIMITED (GB) 1997-03-06 WO disclosed